Recommendations on post-exposure prophylaxis are based on
available efficacy data and on the likelihood of future HBV exposure for the
person requiring treatment. In all exposures, a regimen combining Hepatitis B
Immune Globulin (Human) with hepatitis B vaccine will provide both short- and
long-term protection, will be less costly than the two-dose Hepatitis B Immune
Globulin (Human) treatment alone, and is the treatment of choice.8
BayHep B (hepatitis b immune globulin (human)) is indicated for post-exposure prophylaxis in the
following situations:
Acute ...
Read the complete drug monograph for BayHep B »